Tag Archives: USPTO

Revised 2014 Interim Guidance on Patent Subject Matter Eligibility Released by PTO

Posted on December 16, 2014 by Warren Woessner

On Monday, December 15th, the Patent Office released revised “Guidance” on the evaluation of subject matter patent-eligibility under s. 101. (A copy is available at the end of this post.) The “Guidance” is an attempt to unify the analyses that … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged biotechnology, intellectual property, ip, IP law tools, Patent Law, patents, USPTO, Warren Woessner | Leave a comment

Section 101 at AIPLA

Posted on October 24, 2014 by Warren Woessner

The increasingly intense conversation about patentable subject matter post-Mayo, Myriad and Alice got off to a slow start at the “Partnering for Patents” meeting held at the PTO on Wednesday. The meeting was a scattering of in-house PTO reports and … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged AIPLA, biotechnology, biotechnology law, intellectual property, ip, Patent Law, patents, USPTO, Warren Woessner | Leave a comment

Partnering In Patents XXI Program At USPTO Oct 22nd

Posted on October 21, 2014 by Warren Woessner

Since I am suffering from section 101 fatigue, tomorrow I will be speaking at this program on indefiniteness post-Nautilus. However, this meeting gets interesting earlier in the afternoon when Andrew Hirschfeld presents on “Updates on 101 training and Examiner Guidance” … Continue reading →

Posted in Miscellaneous | Tagged Patent Law, patents, Section 101, USPTO, Warren Woessner | Leave a comment

BIO Provides Supplemental Comments on PTO s.101 Guidelines

Posted on October 21, 2014 by Warren Woessner

BIO recently generated a letter to the PTO on the March 6th Guidelines on the patent-eligibility of subject matter in the life sciences, particularly “natural products.” BIO invited a group of in-house and private practitioners to comment on the Guidelines … Continue reading →